Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27796062 | 0.86 | DNM1 (0.36) | TSHR | |
| SCHEMBL16500125 | 0.85 | — | — | |
| SCHEMBL3885820 | 0.85 | — | — | |
| SCHEMBL6996078 | 0.84 | TSHR (0.40) | METAP1TSHR | |
| SCHEMBL4654300 | 0.78 | METAP1 (0.37) | METAP1TSHR | |
| SCHEMBL1402304 | 0.78 | — | — | |
| SCHEMBL56390 | 0.78 | — | — | |
| SCHEMBL9232363 | 0.77 | DNM1 (0.38) | TSHR | |
| SCHEMBL28049417 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL598768 | 0.75 | TSHR (0.44) | METAP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103068786-B | Cosmetic preparation | COGNIS IP MANAGEMENT GMBH (DE) | 2016-01-20 | — | — | CN | claimed |
| US-8940943-B2 | Cosmetic preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2015-01-27 | — | — | US | claimed |
| EP-2601166-A1 | COSMETIC PREPARATIONS | Cognis IP Management GmbH (DE) | 2013-06-12 | — | — | EP | claimed |
| US-20130131188-A1 | Cosmetic Preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2013-05-23 | — | — | US | claimed |
| CN-103068786-A | Cosmetic preparation | COGNIS IP MAN GMBH | 2013-04-24 | — | — | CN | claimed |
| EP-2426101-A1 | Cosmetic preparations | Cognis IP Management GmbH (DE) | 2012-03-07 | — | — | EP | claimed |
| WO-2012016642-A1 | COSMETIC PREPARATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2012-02-09 | — | — | WO | claimed |
| EP-1858480-B3 | COSMETIC COMPOSITIONS COMPRISING ESTER BASED ON 2-PROPYLHEPTANOL | COGNIS IP MAN GMBH (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-9315716-B2 | Use of surfactant mixtures for tertiary mineral oil extraction | BASF SE (DE) | 2016-04-19 | — | — | US | disclosed |
| CN-103068786-B | Cosmetic preparation | COGNIS IP MANAGEMENT GMBH (DE) | 2016-01-20 | — | — | CN | disclosed |
| US-8940943-B2 | Cosmetic preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2015-01-27 | — | — | US | disclosed |
| EP-2268764-B1 | USE OF TENSIDE MIXTURES FOR TERTIARY OIL PRODUCTION | BASF SE (DE) | 2014-03-12 | — | — | EP | disclosed |
| EP-2601166-A1 | COSMETIC PREPARATIONS | Cognis IP Management GmbH (DE) | 2013-06-12 | — | — | EP | disclosed |
| US-20110190175-A1 | USE OF SURFACTANT MIXTURES FOR TERTIARY MINERAL OIL EXTRACTION | BASF SE (DE) | 2011-08-04 | — | — | US | disclosed |
| US-7985718-B2 | Use of surfactant mixtures for tertiary mineral oil extraction | BASF SE (DE) | 2011-07-26 | — | — | US | disclosed |
| EP-2268764-A1 | USE OF TENSIDE MIXTURES FOR TERTIARY OIL PRODUCTION | BASF SE (DE) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009130141-A1 | USE OF TENSIDE MIXTURES FOR TERTIARY OIL PRODUCTION | BASF SE (DE) | 2009-10-29 | — | — | WO | disclosed |
| US-20090270281-A1 | USE OF SURFACTANT MIXTURES FOR TERTIARY MINERAL OIL EXTRACTION | BASF SE (DE) | 2009-10-29 | — | — | US | disclosed |
| EP-1858480-A1 | COSMETIC COMPOSITIONS CONTAINING ESTERS BASED ON 2-PROPYLHEPTANOL | Cognis IP Management GmbH (DE) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006097235-A1 | COSMETIC COMPOSITIONS CONTAINING ESTERS BASED ON 2-PROPYLHEPTANOL | COGNIS IP MANAGEMENT GMBH (DE) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131188-A1 | Cosmetic Preparations | CYP1B1, CBR1, ACOX3 | METAP1 4232/4885TSHR 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.